Cover Image
市場調查報告書

年輕型骨髓單核細胞性白血病 (JMML) :全球臨床實驗檢討

Juvenile Myelomonocytic Leukemia (JMML) Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 298075
出版日期 內容資訊 英文 100 Pages
訂單完成後即時交付
價格
Back to Top
年輕型骨髓單核細胞性白血病 (JMML) :全球臨床實驗檢討 Juvenile Myelomonocytic Leukemia (JMML) Global Clinical Trials Review, H1, 2014
出版日期: 2014年03月19日 內容資訊: 英文 100 Pages
簡介

本報告提供全球年輕型骨髓單核細胞性白血病治療藥臨床實驗的相關調查,各地區,Phase別,各狀態臨床實驗趨勢,及主要企業和研究機關,醫院等臨床實驗簡介彙整,為您概述為以下內容。

目錄

簡介

  • 年輕型骨髓單核細胞性白血病
  • 報告指南

臨床試驗:各地區

  • 臨床試驗:各國
    • 對臨床實驗有所貢獻的前五國 - 亞太地區
    • 對臨床實驗有所貢獻的前五國 - 歐洲
    • 對臨床實驗有所貢獻的前幾名國家 - 北美
    • 對臨床實驗有所貢獻的前幾名國家 - 中南美

臨床試驗 G7各國

臨床試驗 G7各國,Phase別

臨床試驗 G7各國,各臨床實驗狀態

臨床試驗 Phase別

  • 進行中的臨床實驗:Phase別

臨床試驗:各臨床實驗狀態

未完成的臨床實驗

一定期間的被實驗人數

有力的贊助商

潛力治療藥物

臨床試驗簡介

  • 臨床試驗概要:前幾名企業
    • Merck & Co., Inc
  • 臨床試驗概要:最高級大學 / 研究機關 / 醫院
    • Fred Hutchinson Cancer Research Center
    • National Cancer Institute
    • Children's Oncology Group
    • Roswell Park Cancer Institute
    • Thomas Jefferson University
    • University of California, San Francisco
    • Columbia University
    • Wake Forest University
    • Masonic Cancer Center

5件主要臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二次調查
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

圖表

目錄
Product Code: GDHC2042CTIDB

GlobalData's clinical trial report, "Juvenile Myelomonocytic Leukemia (JMML) Global Clinical Trials Review, H1, 2014" provides data on the Juvenile Myelomonocytic Leukemia (JMML) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Juvenile Myelomonocytic Leukemia (JMML). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Juvenile Myelomonocytic Leukemia (JMML). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Juvenile Myelomonocytic Leukemia (JMML)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Juvenile Myelomonocytic Leukemia (JMML) to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Juvenile Myelomonocytic Leukemia (JMML)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Fred Hutchinson Cancer Research Center
      • Clinical Trial Overview of Fred Hutchinson Cancer Research Center
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Children's Oncology Group
      • Clinical Trial Overview of Children's Oncology Group
      • Roswell Park Cancer Institute
      • Clinical Trial Overview of Roswell Park Cancer Institute
      • Thomas Jefferson University
      • Clinical Trial Overview of Thomas Jefferson University
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • Columbia University
      • Clinical Trial Overview of Columbia University
      • Wake Forest University
      • Clinical Trial Overview of Wake Forest University
      • Masonic Cancer Center
      • Clinical Trial Overview of Masonic Cancer Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Juvenile Myelomonocytic Leukemia (JMML) to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2014*

List of Figures

  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Juvenile Myelomonocytic Leukemia (JMML) to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top